DGAP-News: MPH Mittelständische Pharma Holding AG: Information on the issuance of new shares in connection with the capital increase from company funds and the conversion of preference shares into ordinary shares - trading under new WKN and ISIN

        Print
| Source: EQS Group AG
DGAP-News: MPH Mittelständische Pharma Holding AG / Key word(s):
Capital Increase/Dividend
MPH Mittelständische Pharma Holding AG: Information on the issuance of
new shares in connection with the capital increase from company funds
and the conversion of preference shares into ordinary shares - trading
under new WKN and ISIN

03.09.2014 / 14:19

---------------------------------------------------------------------

The Annual General Shareholders' Meeting from June 27, 2014 has resolved,
inter alia, to increase the share capital of the company from company funds
while issuing one new share on 25 existing shares. Furthermore, the
conversion of the preference shares without voting rights into ordinary
shares with voting rights was passed.

The capital increase from company funds was implemented by converting a
portion of the amount of capital and revenue reserves, amounting to
5,928,071.20 Euro as of December 31, 2013. Company's share capital was
increased from corporate funds by 1,646,687.00 Euro from 41,167,155.00 Euro
to 42,813,842.00 Euro. The capital increase was implemented by the issue of
1,646,687 new, no-par bearer shares, to the shareholder in a ratio of 25:1,
meaning that one new bearer share will be allocated additionally for every
twenty five existing shares.

In addition, the company announces the implementation of the resolution of
the Annual General Shareholders' Meeting and of the separate meeting of
preference share holders on the conversion of the preference shares without
voting rights into ordinary shares with voting rights by cancelling the
preference rights of the preference shares. Thereby, the preference shares
were merged with the ordinary shares. All shares are publicly traded under
WKN A0L1H3 (ISIN: DE000A0L1H32) with immediate effect. Concerning this
matter, the company points out that orders relating the preference shares
have been deleted and have to be replaced.

In accordance to the resolutions, the Articles of the Association and the
global certificate have been adjusted in the meantime.

The capital increase from company funds and the conversion of the
preference shares into ordinary shares as well as the respective amendments
in the Articles of Association were entered in the commercial register on
July 10, 2014 and thereby became effective.

Due to the company's success the Management Board of the company has
decided to propose the issuance of new shares through a capital increase
from company funds to enable shareholders the participation in this
success.

About MPH Mittelständische Pharma Holding AG:
The company MPH Mittelständische Pharma Holding AG, based in Berlin, has
strategically concentrated its activities on the growth segments of the
healthcare market and is aimed to make a contribution towards cutting costs
in the healthcare system.

The focus lies on medicines manufactured on the basis of patent-free and
patent-protected active substances for the therapy of chronic diseases.
Complementary, services for individual patient therapies, aesthetic
surgeries and other medical treatments are offered along the
value-added-chain in the healthcare market.

MPH Mittelständische Pharma Holding AG is listed in the Entry Standard
(Open Market) of the Frankfurt stock exchange.
Key figures for the share of MPH Mittelständische Pharma Holding AG:
Subscribed capital: EUR 42,813,842.00.
ISIN: DE000A0L1H32
WKN: A0L1H3

Contact: Frau Linda Reichelt
MPH Mittelständische Pharma Holding AG
Fasanenstraße 77
D-10623 Berlin

Phone:+49 (0)30 897308660 Fax:+49 (0)30 897308669
E-Mail: ir@mph-ag.de   Web: www.mph-ag.de



---------------------------------------------------------------------

03.09.2014 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


Language:    English                                                     
Company:     MPH Mittelständische Pharma Holding AG                      
             Fasanenstraße 77                                            
             10623 Berlin                                                
             Germany                                                     
Phone:       030 / 897 308 660                                           
Fax:         030 / 897 308 669                                           
E-mail:      info@mph-ag.de                                              
Internet:    www.mph-ag.de                                               
ISIN:        DE000A0L1H32                                                
WKN:         A0L1H3                                                      
Listed:      Freiverkehr in Berlin, Düsseldorf, Stuttgart; Frankfurt in  
             Open Market (Entry Standard)                                
 
 
End of News    DGAP News-Service  
---------------------------------------------------------------------  
285398 03.09.2014